ADMA Biologics (ADMA) Surges: Stock Moves 8.6% Higher
ADMA Biologics, Inc. ADMA was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands more...
Rainmaker Worldwide And Sphere 3D Are Taking Advantage Of An Ocean of Opportunity; Technology Can Generate Fresh Water For Millions
New York, New York–(Newsfile Corp. – October 1, 2020) – Many companies set out to change the world. But other than having a catchy phrase in their tagline, few actually rise to the challenge. One more...
PPD Looks Good: Stock Adds 5.2% in Session
PPD, Inc. PPD was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands more...
ViewRay (VRAY) Catches Eye: Stock Jumps 7%
ViewRay, Inc. VRAY was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands more...
Acer Therapeutics to Present at the Virtual BIO Investor Forum Digital
NEWTON, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical more...
ROCCAT’s All-New Elo Series PC Gaming Headsets Available At Participating Retailers Worldwide Sunday, October 4, 2020
TURTLE-BEACH-ROCCAT ROCCAT’s All-New Elo Series PC Gaming Headsets Available At Participating Retailers Worldwide Sunday, October 4, 2020 ROCCAT Also Launches New Compact Vulcan TKL PC Gaming Keyboards and the Sense AIMO XXL Mousepad PR Newswire more...
Silicom’s Third Quarter 2020 Results Release Scheduled For October 29, 2020
Silicom-Results-Note Silicom’s Third Quarter 2020 Results Release Scheduled For October 29, 2020 – Conference Call Scheduled for Thursday, October 29, 2020 at 9:00am ET – PR Newswire KFAR SAVA, Israel, Oct. 1, 2020 KFAR SAVA, more...
CymaBay Therapeutics to Present Data from its Phase 2 Study of Seladelpar in Patients with NASH at The Liver Meeting® 2020
NEWARK, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced more...
Oncocyte Agrees to Enter Licensing and Collaboration Agreement with Chronix Biomedical
Chronix’s blood – based test monitors the effectiveness of immunotherapy drugs in clinical trials , and potentially in patients receiving immunotherapy treatment Further extends Onco c yte ’s product portfolio across the continuum of cancer more...
DLH Acquires IBA to Bolster its DoD Health Technology Capabilities
Transaction Expands Data Analytics, AI, and Research & Development Profile ATLANTA, Oct. 01, 2020 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare research, services and more...